HUMANA INC. UNDERWRITING AGREEMENTUnderwriting Agreement • March 22nd, 2022 • Humana Inc • Hospital & medical service plans • New York
Humana Inc., a Delaware corporation (the “Company”), proposes to sell $750,000,000 in aggregate principal amount of the Company’s 3.700% Senior Notes due 2029 (the “Notes”). The Notes are to be issued pursuant to an Indenture, dated as of August 5, 2003 (the “Base Indenture”), as supplemented by the Twenty-First Supplemental Indenture, to be dated as of March 23, 2022 (the “Supplemental Indenture”; the Base Indenture, as supplemented by the Supplemental Indenture, the “Indenture”), to be entered into between the Company and The Bank of New York Mellon Trust Company, N.A. (formerly known as The Bank of New York Trust Company, N.A.) (as successor to The Bank of New York), as trustee (the “Trustee”). This is to confirm the agreement concerning the purchase of the Notes from the Company by the Underwriters named in Schedule 1 hereto (the “Underwriters”).
